Clinical usefulness of quantiFERON TB-2G test for the early diagnosis of pulmonary Mycobacterium kansasii disease

Japanese Journal of Infectious Diseases

Volumn 62, Issue 3, 2009, Pages 239-241

  Kobashi, Yoshihiro ^a   Mouri, Keiji ^a   Miyashita, Naoyuki ^a   Oka, Mikio ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; GAMMA INTERFERON; ISONIAZID; RIFAMPICIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CFP 10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOASSAY; LUNG LAVAGE; MALE; MYCOBACTERIUM KANSASII; QUANTIFERON TB GOLD TEST; TREATMENT RESPONSE; TUBERCULIN TEST; ATYPICAL MYCOBACTERIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; METABOLISM; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED;

AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 69249223065     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Arend, S.M., van Meijgaarden, K.E., de Boer, K., et al. (2002): Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrateprotein 10 after infection with Mycobacterium marinum or M. kansasii. J. Infect. Dis., 186, 1797-1807.
2. Mazurek, G.H., Jereb, J., Lobue, P., et al. (2005): Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. Morbid. Mortal. Wkly. Rep., 54 (RR-15), 49-56.
3. Rothel, J.S. and Andersen, P. (2005): Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev. Anti. Infect. Ther., 3, 981-993.
4. American Thoracic Society (2000): Targeted tuberculin testing and treatment of latent tuberculosis infection. Morbid. Mortal. Wkly. Rep., 49 (RR-6), 1-51.
5. Arend, S.M., Andersen, P., van Meijgaarden, K.E., et al. (2000): Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J. Infect. Dis., 181, 1850-1854.
6. Griffith, D.J., Aksamit, T., Brown-Elliott, B.A., et al. (2007): An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med., 175, 367-416.